HIGHLIGHTS
- who: Christoph Schwepcke and collaborators from the Department of Medicine III, University Hospital of Munich, Munich, Germany have published the research: Generation of Leukaemia-Derived Dendritic Cells (DCleu) to Improve Anti-Leukaemic Activity in AML: Selection of the Most Efficient Response Modifier Combinations, in the Journal: (JOURNAL)
- what: The authors developed DC/DCleu -generating protocols specifically designed for the generation of DC/DCleu in a WB-environment and evaluated their potential to generate DC/DCleu and mediate DC/DCleu -based anti-leukaemic immunity. The authors could show that kits are competent to generate (mature) DC . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.